Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Nausea is the most common adverse effect , occurring in approximately 40-50% of patients taking GLP-1 receptor agonists, though rates vary by product and dose according to clinical trials (STEP trials for semaglutide
These compounded medications are not generic versions of FDA-approved branded medications such as Ozempic, Wegovy, Zepbound, or Mounjaro
Clinical trials on a large scale and safety data collected after marketing have not shown proof that GLP-1 therapies cause lasting menstrual issues
There is no absolute pharmacokinetic incompatibility between semaglutide and moderate alcohol consumption
Schedule an in-clinic consultation to review the process and discuss your goals.
Side Effects Profile and Safety Considerations Common Gastrointestinal Effects The safety profile of GLP-1 medications is predominantly characterized by gastrointestinal adverse events ^6
US$ 24.93
US$ 22.18
US$ 27.08
US$ 28.79
US$ 26.89
